Status:
COMPLETED
Fatty Acid Binding Protein 2 (FABP2) Ancillary Proposal
Lead Sponsor:
US Department of Veterans Affairs
Collaborating Sponsors:
American Diabetes Association
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
40+ years
Brief Summary
TITLE: CSP 465-C, Fatty Acid Binding protein 2 (FABP2) ancillary proposal to CSP# 465 Glycemic Control and Complications in Diabetes Mellitus Type 2. Angeliki Georgopoulos, M.D. Carlos Abraira M.D. W...
Detailed Description
Primary Hypothesis: Secondary Hypotheses: Primary Outcomes: Major cardiovascular events Study Abstract: TITLE: CSP 465-C, Fatty Acid Binding protein 2 (FABP2) ancillary proposal to CSP# 465 Glycem...
Eligibility Criteria
Inclusion
- Patients with type 2 DM who are no longer responsive to maximum dose of one or more oral agents.
Exclusion
- Patients not registered in the VADT.
Key Trial Info
Start Date :
April 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
874 Patients enrolled
Trial Details
Trial ID
NCT00256633
Start Date
April 1 2007
End Date
May 1 2008
Last Update
May 23 2014
Active Locations (16)
Enter a location and click search to find clinical trials sorted by distance.
1
Carl T. Hayden VA Medical Center
Phoenix, Arizona, United States, 85012
2
Southern Arizona VA Health Care System, Tucson
Tucson, Arizona, United States, 85723
3
VA Central California Health Care System, Fresno
Fresno, California, United States, 93703
4
VA San Diego Healthcare System, San Diego
San Diego, California, United States, 92161